Marc Davies
MD
Marc Davies
VP R&D
Rate
About
Marc Davies received his PhD from King's College London, where his research focused on the development and pre-clinical assessment of CAR T-cells. He has over 15 years' experience in adoptive cell therapy and joined Leucid Bio in May 2021 as VP of CAR Engineering, now VP R&D, to manage their CAR T-cell R&D pipeline and clinical translation of their lead asset, LEU011.
Frequently asked
Who is Marc Davies?
Marc Davies received his PhD from King's College London, where his research focused on the development and pre-clinical assessment of CAR T-cells. He has over 15 years' experience in adoptive cell therapy and joined Leucid Bio in May 2021 as VP of CAR Engineering, now VP R&D, to manage their CAR T-cell R&D pipeline and clinical translation of their lead asset, LEU011.
What is Marc Davies's current role?
Marc Davies is currently VP R&D.
Comments
No comments yet. Be the first to share your take.
Profile
About Marc Davies
Marc Davies is VP R&D. This profile tracks their companies, funding activity, and news mentions across the AI ecosystem.